MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

Part of paid clinical trials in Chicago, Illinois.

Sponsor
CorVita Science Foundation
Study ID
NCT06455488
Status
Recruiting
Apply to this trial

Conditions

  • Ventricular Tachycardia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Ventricular Tachycardia Ablation — PROCEDURE
    This is a surgical ablation meant to reset patients irregular rhythm back to sinus.
  • ICD Implant — DEVICE
    A pacemaker or defibrillator implant to prevent SCD
  • Antiarrhythmic drug — DRUG
    Drug therapies
  • EKG — DIAGNOSTIC_TEST
    Monitoring EKG testing done on registry patients
  • Cardioversion — DIAGNOSTIC_TEST
    Monitoring cardioversions on registry patients
  • Echocardiogram — DIAGNOSTIC_TEST
    Monitoring echocardiogram testing done on patients

Study Details

Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.

Key Dates

Start date
Jul 20, 2020
Status verified
Jun 2024
Primary completion
Jul 20, 2030
Completion
Jul 20, 2030

Study Design

Enrollment
130 participants (estimated)

Arms

  • Arm: MANAGE-VT Patients
    Patients will be assessed on the status of their ventricular tachycardia as well as other criteria such as: EKG,

Primary Outcome Measure

Recurrence of Ventricular Tachycardia [ Time Frame: July 20, 2020 - Present ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Corvita Science FoundationChicagoIllinois60643
Martin C Burke, DO
[email protected]
773-520-8322
Edward M Burke
[email protected]
7737297956

Find similar trials in Chicago, IL

By research site
Corvita Science Foundation· Chicago, IL

Related Studies